Endocarditis historical background: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 5: | Line 5: | ||
==Overview== | ==Overview== | ||
Endocarditis was first described in 1554. The inflammatory process associated with endocarditis was discovered in 1799. Vegetations were first discovered to be associated with endocarditis in 1806. | |||
==Historical Perspective== | ==Historical Perspective== | ||
| Line 11: | Line 11: | ||
*1554: Earliest report of endocarditis in medical books | *1554: Earliest report of endocarditis in medical books | ||
*1669: Accurately described [[tricuspid valve]] | *1669: Accurately described [[tricuspid valve]] endocarditis | ||
*1646: Described unusual "outgrowths" from [[autopsy]] of patient with endocarditis; detected | *1646: Described unusual "outgrowths" from [[autopsy]] of patient with endocarditis; detected [[murmur]]s by placing hand on patient's chest | ||
*1708: Described unusual structures in entrance of [[aorta]] | *1708: Described unusual structures in entrance of [[aorta]] | ||
*1715: Described abnormality in [[aortic|aortic valve]] and [[mitral valve]] | *1715: Described abnormality in [[aortic|aortic valve]] and [[mitral valve]] | ||
*1749: Described valvular lesions | *1749: Described valvular lesions | ||
*1769: Linked infectious disease and | *1769: Linked infectious disease and endocarditis; observed association with the [[spleen]] | ||
*1784: Accurately drew intracardiac abnormalities | *1784: Accurately drew intracardiac abnormalities | ||
*1797: Showed relationship between rheumatism and heart disease | *1797: Showed relationship between rheumatism and [[heart disease]] | ||
*1799: Described inflammatory process associated with | *1799: Described inflammatory process associated with endocarditis | ||
*1806: Described unusual structures in heart as "vegetations," syphilitic virus as causative agent of | *1806: Described unusual structures in heart as "vegetations," syphilitic virus as causative agent of endocarditis, and theory of antiviral treatment of endocarditis | ||
*1809: Indicated vegetations were not "outgrowths" or "buds" but particles adhering to heart wall | *1809: Indicated vegetations were not "outgrowths" or "buds" but particles adhering to heart wall | ||
*1815: Elucidated inflammatory processes associated with | *1815: Elucidated inflammatory processes associated with endocarditis | ||
*1816: Invented cylindrical stethoscope to listen to heart [[ | *1816: Invented cylindrical [[stethoscope]] to listen to heart [[murmur]]s; dismissed link between venereal disease and endocarditis | ||
*1832: Confirmed Laennec's observations | *1832: Confirmed Laennec's observations | ||
*1835-40: Named [[endocardium]] and [[endocarditis]]; described symptoms; prescribed herbal tea and bloodletting as treatment regimen; described link between acute [[rheumatoid arthritis]] and | *1835-40: Named [[endocardium]] and [[endocarditis]]; described symptoms; prescribed herbal tea and bloodletting as treatment regimen; described link between acute [[rheumatoid arthritis]] and endocarditis | ||
*1852: Described consequences of embolization of vegetations throughout body. Described cutaneous nodules (named "[[Osler's nodes]]" by Libman) | *1852: Described consequences of [[embolization]] of vegetations throughout body. Described cutaneous nodules (named "[[Osler's nodes]]" by Libman) | ||
*1858-71: Examined [[fibrin]] vegetation associated with | *1858-71: Examined [[fibrin]] vegetation associated with endocarditis by microscope; coined term "embolism;" discussed role of [[bacteria]], vibrios, and micrococci in [[endocarditis]] | ||
*1861: Confirmed Virchow's theory on [[emboli]] | *1861: Confirmed Virchow's theory on [[emboli]] | ||
*1862: Described granulations or foreign elements in blood and | *1862: Described granulations or foreign elements in blood and [[valve]]s, which were motile and resistant to alkalis | ||
*1868-70: Described infected arterial blood as originating from heart; proposed [[scarlet fever]] as cause of | *1868-70: Described infected arterial blood as originating from heart; proposed [[scarlet fever]] as cause of endocarditis | ||
*1869: Established "parasites" on skin transported to heart and attached to [[endocardium]]; named "mycosis endocardii" | *1869: Established "parasites" on skin transported to heart and attached to [[endocardium]]; named "mycosis endocardii" | ||
*1872: Detected microorganisms in vegetations of | *1872: Detected microorganisms in vegetations of endocarditis | ||
*1878: All cases of | *1878: All cases of endocarditis were infectious in origin | ||
*1878: Combined experimental physiology and infection to produce animal model of | *1878: Combined experimental physiology and infection to produce animal model of endocarditis in rabbit; noted valve had to be damaged before [[bacteria]] grafted onto valve | ||
*1878: Micrococci enter vessels that valves were fitted into; valves exposed to abnormal mechanical attacks over long period created favorable niche for bacterial colonization | *1878: Micrococci enter vessels that valves were fitted into; valves exposed to abnormal mechanical attacks over long period created favorable niche for bacterial colonization | ||
*1879: Virchow's student; employed early animal model of | *1879: Virchow's student; employed early animal model of endocarditis | ||
*1879: Proposed etiology of | *1879: Proposed etiology of endocarditis was based on infectious model and treatment should focus on eliminating "parasitic infection" | ||
*1880: Working with Pasteur, proposed use of routine blood cultures | *1880: Working with Pasteur, proposed use of routine blood cultures | ||
*1881-86: Believed | *1881-86: Believed endocarditis could appear during various infections; noted translocation of respiratory pathogen from pulmonary lesion to valve through blood | ||
*1883: Believed microorganisms were result, not cause, of endocarditis | *1883: Believed microorganisms were result, not cause, of endocarditis | ||
*1884: Named disease "[[infective endocarditis]]" | *1884: Named disease "[[infective endocarditis]]" | ||
*1886: Demonstrated various bacteria introduced to bloodstream could cause | *1886: Demonstrated various bacteria introduced to bloodstream could cause endocarditis on valve that had previous lesion | ||
*1885: Synthesized work of others relating to | *1885: Synthesized work of others relating to endocarditis | ||
*1899: Described streptococcal, staphylococcal, pneumococcal, and gonococcal endocarditis | *1899: Described streptococcal, staphylococcal, pneumococcal, and gonococcal endocarditis | ||
*1903: First described "endocarditis lenta" | *1903: First described "endocarditis lenta" | ||
*1909: Credited by Osler as first to observe cutaneous nodes (named " | *1909: Credited by Osler as first to observe cutaneous nodes (named "Osler's nodes" by Libman) in patients with endocarditis | ||
*1909: Analyzed 150 cases of | *1909: Analyzed 150 cases of endocarditis and published diagnostic criteria relating to signs and symptoms | ||
*1910: Described initial classification scheme to include "subacute endocarditis," with clinical signs/symptoms; absolute diagnosis required blood cultures | *1910: Described initial classification scheme to include "[[subacute endocarditis]]," with clinical signs/symptoms; absolute diagnosis required blood cultures | ||
*1981: Described Beth Israel criteria based on strict case definitions | *1981: Described Beth Israel criteria based on strict case definitions | ||
*1994: New criteria utilizing specific echocardiographic findings | *1994: New criteria utilizing specific echocardiographic findings | ||
*1995: Antibiotic treatment of adults with [[infective endocarditis]] caused by streptococci, enterococci, staphylococci, and | *1995: Antibiotic treatment of adults with [[infective endocarditis]] caused by streptococci, enterococci, staphylococci, and HACEK microorganisms | ||
*1996: Modified [http://www.medcalc.com/endocarditis.html Duke Criteria] to allow serologic diagnosis of [[Coxiella burnetii]] | *1996: Modified [http://www.medcalc.com/endocarditis.html Duke Criteria] to allow serologic diagnosis of ''[[Coxiella burnetii]]'' | ||
*1997: Guidelines for preventing bacterial | *1997: Guidelines for preventing bacterial endocarditis | ||
*1997: Suggested modifications to Duke criteria for clinical diagnosis of native valve and prosthetic valve endocarditis: | *1997: Suggested modifications to Duke criteria for clinical diagnosis of native valve and [[prosthetic valve]] endocarditis: analysis of 118 pathologically proven cases | ||
*1998: Guidelines for [[antibiotic]] treatment of streptococcal, enterococcal, and staphylococcal endocarditis | *1998: Guidelines for [[antibiotic]] treatment of streptococcal, enterococcal, and staphylococcal endocarditis | ||
*1998: Antibiotic treatment of infective endocarditis due to viridans streptococci, enterococci, and other streptococci; recommendations for surgical treatment of endocarditis | *1998: Antibiotic treatment of infective endocarditis due to viridans streptococci, enterococci, and other streptococci; recommendations for surgical treatment of endocarditis | ||
*2000: Updated and modified [http://www.medcalc.com/endocarditis.html Duke Criteria] | *2000: Updated and modified [http://www.medcalc.com/endocarditis.html Duke Criteria] | ||
*2002: [http://www.medcalc.com/endocarditis.html Duke Criteria] to include a molecular diagnosis of causal agents | *2002: [http://www.medcalc.com/endocarditis.html Duke Criteria] to include a molecular diagnosis of causal agents | ||
*2001-3: Described etiology of Bartonella spp., [[Tropheryma whipplei]], and [[Coxiella burnetii]] in | *2001-3: Described etiology of [[Bartonella]] spp., ''[[Tropheryma whipplei]]'', and ''[[Coxiella burnetii]]'' in endocarditis | ||
==References== | ==References== | ||
| Line 68: | Line 68: | ||
[[Category:Infectious disease]] | [[Category:Infectious disease]] | ||
[[Category:Intensive care medicine]] | [[Category:Intensive care medicine]] | ||
[[Category: Up-To-Date]] | [[Category:Up-To-Date]] | ||
{{WH}} | {{WH}} | ||
{{WS}} | {{WS}} | ||
Revision as of 17:20, 16 September 2015
|
Endocarditis Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease |
|
Case Studies |
|
Endocarditis historical background On the Web |
|
Risk calculators and risk factors for Endocarditis historical background |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor-in-Chief: Cafer Zorkun, M.D., Ph.D. [2]
Overview
Endocarditis was first described in 1554. The inflammatory process associated with endocarditis was discovered in 1799. Vegetations were first discovered to be associated with endocarditis in 1806.
Historical Perspective
Important landmarks in the history of endocarditis include the following:
- 1554: Earliest report of endocarditis in medical books
- 1669: Accurately described tricuspid valve endocarditis
- 1646: Described unusual "outgrowths" from autopsy of patient with endocarditis; detected murmurs by placing hand on patient's chest
- 1708: Described unusual structures in entrance of aorta
- 1715: Described abnormality in aortic valve and mitral valve
- 1749: Described valvular lesions
- 1769: Linked infectious disease and endocarditis; observed association with the spleen
- 1784: Accurately drew intracardiac abnormalities
- 1797: Showed relationship between rheumatism and heart disease
- 1799: Described inflammatory process associated with endocarditis
- 1806: Described unusual structures in heart as "vegetations," syphilitic virus as causative agent of endocarditis, and theory of antiviral treatment of endocarditis
- 1809: Indicated vegetations were not "outgrowths" or "buds" but particles adhering to heart wall
- 1815: Elucidated inflammatory processes associated with endocarditis
- 1816: Invented cylindrical stethoscope to listen to heart murmurs; dismissed link between venereal disease and endocarditis
- 1832: Confirmed Laennec's observations
- 1835-40: Named endocardium and endocarditis; described symptoms; prescribed herbal tea and bloodletting as treatment regimen; described link between acute rheumatoid arthritis and endocarditis
- 1852: Described consequences of embolization of vegetations throughout body. Described cutaneous nodules (named "Osler's nodes" by Libman)
- 1858-71: Examined fibrin vegetation associated with endocarditis by microscope; coined term "embolism;" discussed role of bacteria, vibrios, and micrococci in endocarditis
- 1861: Confirmed Virchow's theory on emboli
- 1862: Described granulations or foreign elements in blood and valves, which were motile and resistant to alkalis
- 1868-70: Described infected arterial blood as originating from heart; proposed scarlet fever as cause of endocarditis
- 1869: Established "parasites" on skin transported to heart and attached to endocardium; named "mycosis endocardii"
- 1872: Detected microorganisms in vegetations of endocarditis
- 1878: All cases of endocarditis were infectious in origin
- 1878: Combined experimental physiology and infection to produce animal model of endocarditis in rabbit; noted valve had to be damaged before bacteria grafted onto valve
- 1878: Micrococci enter vessels that valves were fitted into; valves exposed to abnormal mechanical attacks over long period created favorable niche for bacterial colonization
- 1879: Virchow's student; employed early animal model of endocarditis
- 1879: Proposed etiology of endocarditis was based on infectious model and treatment should focus on eliminating "parasitic infection"
- 1880: Working with Pasteur, proposed use of routine blood cultures
- 1881-86: Believed endocarditis could appear during various infections; noted translocation of respiratory pathogen from pulmonary lesion to valve through blood
- 1883: Believed microorganisms were result, not cause, of endocarditis
- 1884: Named disease "infective endocarditis"
- 1886: Demonstrated various bacteria introduced to bloodstream could cause endocarditis on valve that had previous lesion
- 1885: Synthesized work of others relating to endocarditis
- 1899: Described streptococcal, staphylococcal, pneumococcal, and gonococcal endocarditis
- 1903: First described "endocarditis lenta"
- 1909: Credited by Osler as first to observe cutaneous nodes (named "Osler's nodes" by Libman) in patients with endocarditis
- 1909: Analyzed 150 cases of endocarditis and published diagnostic criteria relating to signs and symptoms
- 1910: Described initial classification scheme to include "subacute endocarditis," with clinical signs/symptoms; absolute diagnosis required blood cultures
- 1981: Described Beth Israel criteria based on strict case definitions
- 1994: New criteria utilizing specific echocardiographic findings
- 1995: Antibiotic treatment of adults with infective endocarditis caused by streptococci, enterococci, staphylococci, and HACEK microorganisms
- 1996: Modified Duke Criteria to allow serologic diagnosis of Coxiella burnetii
- 1997: Guidelines for preventing bacterial endocarditis
- 1997: Suggested modifications to Duke criteria for clinical diagnosis of native valve and prosthetic valve endocarditis: analysis of 118 pathologically proven cases
- 1998: Guidelines for antibiotic treatment of streptococcal, enterococcal, and staphylococcal endocarditis
- 1998: Antibiotic treatment of infective endocarditis due to viridans streptococci, enterococci, and other streptococci; recommendations for surgical treatment of endocarditis
- 2000: Updated and modified Duke Criteria
- 2002: Duke Criteria to include a molecular diagnosis of causal agents
- 2001-3: Described etiology of Bartonella spp., Tropheryma whipplei, and Coxiella burnetii in endocarditis